The Pediatric Interventional Cardiac Catheterization Program at Yale has a long history of innovation and continues to be a pioneer in minimally invasive therapies for congenital heart disease.
Our laboratory performs diagnostic and interventional catheterization procedures in children and adults with congenital heart disease across the age spectrum. Yale New Haven Children's Hospital's digital pediatric catheterization suite features state-of-the-art equipment that allows for a multidisciplinary approach to patient care.
Procedures commonly performed include closure of atrial septal defect (ASD), patent foramen ovale (PFO) and patent ductus arteriosus (PDA). Ours is the only congenital cardiac catheterization laboratory in Connecticut that offers transcatheter pulmonary valve replacements, including the Melody and Edwards valves.
Our team has expertise in nonsurgical transcatheter treatment of aortic and pulmonary valve stenosis, coarctation of the aorta, intravascular stent placement for narrowed arteries and vessels and blood vessel coil occlusion. Our interventional team also works collaboratively with our pediatric cardiothoracic surgeons to deliver the most innovative hybrid procedures that are intended to minimize operative time and difficulty while improving patient safety.
Members of the congenital cardiac catheterization lab are actively involved in a number of clinical trials to push the noninvasive boundaries to replace pulmonary valves and close atrial septal defects. We participate in pediatric interventional catheterization consortiums and lead efforts to advance the understanding of congenital heart disease and provide the best possible care for patients.